Organogenesis Holdings ORGO Cash Flow Statement (2016-2026)

NASDAQ ORGO
$1.90 -0.01 (-0.52%)
At close: Aug 20, 2026 · 12:46 PM UTC
Cash Flow Statement Mar2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
12.58M19.02M-0.91M8.74M0.21M7.49M-2.97M5.32M3.17M1.44M-2.10M-17.04M12.33M7.67M-18.84M-9.39M21.57M49.10M-53.16M-96.27M
Depreciation and Depletion (Quarter)
1.94M1.77M1.35M1.53M1.46M1.51M2.69M2.23M2.54M2.98M3.07M3.37M3.57M3.62M3.44M3.73M4.03M4.07M
Share-based Compensation (Quarter)
1.04M23.15M0.17M1.69M1.70M0.70M1.91M2.30M2.42M0.73M0.70M2.57M2.71M3.94M1.80M13.54M3.06M-7.09M3.64M23.49M
Deferred Taxes (Quarter)
0.01M-2.20M-0.31M-1.27M-1.03M-3.84M13.45M-15.37M45.33M
Gains from Investment Securities (Quarter)
-0.93M
Asset Writedowns and Impairment (Quarter)
0.87M0.63M0.04M0.08M0.73M-0.85M18.84M
Cash from Operations (Quarter)
27.85M17.95M1.41M10.20M5.45M7.80M-5.08M8.65M16.73M10.61M-10.16M4.74M8.70M10.94M-19.93M-32.87M3.08M39.42M21.13M-31.65M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.09M5.71M1.85M-1.63M0.11M0.11M0.11M3.79M2.07M2.12M2.20M2.16M-4.05M0.08M0.07M0.07M6.05M-5.82M0.09M2.49M
Depreciation & Amortization (CF) (Quarter)
1.94M1.77M1.35M1.53M1.46M1.51M2.69M2.23M2.54M2.98M3.07M3.37M3.57M3.62M3.44M3.73M4.03M4.07M4.17M3.67M
Change in Working Capital
Change in Receivables (Quarter)
-1.31M8.51M-2.94M9.43M5.03M-2.74M3.43M1.54M-3.21M-7.30M15.12M10.86M-2.98M8.80M-5.67M19.30M50.69M51.48M-104.50M-14.99M
Change in Inventory (Quarter)
4.76M-0.44M-0.08M3.52M3.84M2.13M2.16M1.88M3.43M0.71M4.67M-2.66M3.74M0.46M8.73M7.16M-0.94M2.96M8.73M3.08M
Change in Account Payables (Quarter)
4.52M-1.39M-1.19M3.86M2.59M-2.00M-1.39M-2.15M-0.13M3.55M-4.39M2.24M-3.88M3.65M-2.50M4.13M-0.99M-1.17M-2.00M0.60M
Change in Accured Expenses (Quarter)
4.12M-12.83M-3.83M2.13M-2.36M-7.79M0.02M0.04M0.00M0.02M9.99M-9.94M0.03M-1.14M-7.99M8.03M1.43M8.91M0.29M-9.80M
Other Working Capital Changes (Quarter)
-1.55M-0.06M2.17M-0.33M-1.84M0.38M4.77M-1.90M1.62M5.62M4.32M-3.88M3.62M-1.50M5.12M7.82M-9.64M-3.12M1.66M-6.46M
Investing Activities
Capital Expenditures (Quarter)
16.70M5.23M1.87M10.97M10.40M10.66M1.99M-0.10M19.16M3.32M0.79M3.32M2.57M3.36M3.63M3.64M2.23M4.65M3.15M1.10M
Cash from Investing Activities (Quarter)
-16.70M-5.23M-6.67M-6.17M-10.40M-10.66M-7.56M-7.50M-5.98M-3.32M-2.22M-1.88M-2.57M-3.36M-3.63M-3.64M-2.23M-4.65M-3.15M-1.10M
Financing Activities
Other financing activities (Quarter)
0.91M0.08M0.29M1.75M0.03M0.18M0.00M1.06M0.03M0.13M0.00M
Cash from Financing Activities (Quarter)
1.27M-0.92M-0.77M0.41M0.03M-1.88M-1.24M-1.05M-1.44M-1.78M-2.61M-1.73M-1.68M33.65M-2.06M-0.29M-10.21M-4.81M-20.21M-12.50M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Additional items
Change in Cash (Quarter)
12.42M11.80M-6.03M4.44M-4.92M-4.73M-13.88M0.09M9.32M5.51M-14.99M1.13M4.45M41.23M-25.62M-36.80M-9.36M29.96M-2.23M-45.26M
Free Cash Flow (Quarter)
11.15M12.72M-0.46M-0.78M-4.95M-2.86M-7.06M8.75M-2.42M7.29M-10.95M1.42M6.13M7.58M-23.56M-36.51M0.84M34.77M17.98M-32.75M
Net Cash Flow (Quarter)
12.42M11.80M-6.03M4.44M-4.92M-4.73M-13.88M0.09M9.32M5.51M-14.99M1.13M4.45M41.23M-25.62M-36.80M-9.36M29.96M-2.23M-45.26M